CellCentric's Series C Round

CellCentric raised a round of funding on June 25, 2013.

CellCentric is a biotechnology company and early pioneers in epigenetics. Epigenetic mechanisms play a key role in regulating cell fate. When these processes go awry, disease states can be induced, in…

Articles about CellCentric's Series C Round: